Forte Biosciences Inc.

AI Score

0

Unlock

7.75
-1.35 (-14.84%)
At close: Mar 03, 2025, 3:59 PM
7.68
-0.90%
After-hours: Mar 03, 2025, 04:00 PM EST

Forte Biosciences Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue n/a n/a n/a n/a n/a 18.04M 41K 49K 51K
Cost of Revenue 9K n/a 36K 54K 11K n/a n/a n/a n/a
Gross Profit -9K n/a -36K -54K -11K 18.04M 41K 49K 51K
Operating Income -32.49M -13.9M -21.49M 17.83M -4.06M -45.85M -37.63M -31.69M -22.95M
Interest Income 1.12M n/a n/a n/a n/a n/a 595K n/a n/a
Pretax Income -31.48M -13.88M -21.71M -46.49M -4.07M -47.26M -38.93M -33.48M -23.06M
Net Income -31.48M -13.86M -21.71M -78.54M -4.07M -48.95M -38.93M -33.48M -23.06M
Selling & General & Admin 10.62M 8.3M 7.63M 4.22M 1.38M 12.81M 8.27M 4.27M 3.6M
Research & Development 21.86M 5.59M 13.85M 10M 2.68M 50.45M 29.11M 27.22M 19.17M
Other Expenses -1 17K -222K -205K -6.85K n/a n/a -50K n/a
Operating Expenses 32.48M 13.9M 21.49M 14.22M 4.06M 63.26M 37.38M 31.48M 22.77M
Interest Expense n/a n/a n/a n/a n/a 173.38K 1.93M -1.84M -102K
Selling & Marketing Expenses -9K n/a n/a n/a n/a 12.54M -292K -255K -232K
Cost & Expenses 32.49M 13.9M 21.49M 14.22M 4.06M 63.89M 37.67M 31.74M 23M
Income Tax n/a -17K -200.56K 32.06M -2.52K 1.7M -2.6M -3.67M -204K
Shares Outstanding (Basic) 1.26M 695.34K 558.71K 294.36K 84.33K 53.49K 38.95K 52.74K 48.63K
Shares Outstanding (Diluted) 1.26M 695.34K 558.71K 294.36K 84.33K 53.49K 38.95K 52.74K 48.63K
EPS (Basic) -24.92 -19.96 -38.85 -157.93 -48.25 -915.18 -997.5 -634.8 -474.15
EPS (Diluted) -24.92 -19.96 -38.85 -157.93 -48.25 -915.18 -997.5 -634.8 -474.15
EBITDA -32.48M -13.9M -21.45M -46.43M -4.05M -43.69M -36.7M -31.17M -22.48M
Depreciation & Amortization 9K 36K 36K 54K 11K 625K 292K 255K 232K